Organism
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.(Escherichiacoli)
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.(Geobacillusstearothermophilus)
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.(Geobacillusstearothermophilus)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.(Escherichiacoli)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.(Homo sapiens)
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.(Escherichiacoli)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.(Cellvibriojaponicus)
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.(Leishmaniamexicana)
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.(Leishmaniamexicana)
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.(Thermotogamaritima)
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.(Thermotogamaritima)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.(Mus musculus)
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.(Spinaciaoleracea)
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.(Spinaciaoleracea)
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.(Achromobacterxylosoxidans)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.(Vibrio sp.PA-44)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.(Rattusnorvegicus)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.(syntheticconstruct)
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.(Thermusthermophilus)
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.(Thermusthermophilus)
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.(Plasmodiumfalciparum)
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.(Plasmodiumfalciparum)
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.(Synechococcussp.)
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.(Synechococcussp.)
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.(Aquifexaeolicus)
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.(Aquifexaeolicus)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.(Homo sapiens)
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.(Kluyveromycesmarxianus)
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.(Kluyveromycesmarxianus)
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.(Spinaciaoleracea)
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.(Spinaciaoleracea)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.(Ruminiclostridiumthermocellum)
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.(Trypanosomabrucei)
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.(Trypanosomabrucei)
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.(Escherichiacoli)
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.(Escherichiacoli)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.(Rheum palmatum)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.(Geobacillusstearothermophilus)
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.(Synechococcuselongatus)
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.(Synechococcuselongatus)
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.(Cryptosporidiumparvum)
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.(Cryptosporidiumparvum)
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.(Brucellaabortus)
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.(Oryza sativa)
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.(Burkholderiapseudomallei)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.(Picea abies)
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.(Borreliellaburgdorferi)
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.(Borreliellaburgdorferi)
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.(Arabidopsisthaliana)
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.(Arabidopsisthaliana)
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.(Staphylococcusaureus)
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.(Bartonellahenselae)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.(Bacteroidesthetaiotaomicron)
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.(Saccharomycescerevisiae)
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.(Saccharomycescerevisiae)
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.(Toxoplasmagondii)
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.(Toxoplasmagondii)
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.(Thermosynechococcuselongatus)
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.(Thermosynechococcuselongatus)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.(Trichodermaharzianum)
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.(Bacillusanthracis)
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.(Bacillusanthracis)
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.(Bacillusanthracis)
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.(Homarusamericanus)
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.(Homarusamericanus)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.(Mus musculus)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.(Gemmabryumcoronatum)
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.(Brugia malayi)
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.(Brugia malayi)
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.(Trypanosomacruzi)
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.(Trypanosomacruzi)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.(Heveabrasiliensis)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.(Agrobacteriumfabrum)
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.(Bos taurus)
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.(Bos taurus)
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.(Trypanosomabrucei)
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.(Trypanosomabrucei)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.(Shewanellaoneidensis)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.(Enterovirus C)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.([Ruminococcus]gnavus)
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.(Arabidopsisthaliana)
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.(Arabidopsisthaliana)
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.(Mus musculus)
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.(Mus musculus)
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.(Homo sapiens)
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.(Homo sapiens)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.(Schistosomamansoni)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.(Cryptomeriajaponica)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.(Homo sapiens)
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.(Lactobacillusacidophilus)
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.(Atopobiumvaginae)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.(Vanderwaltozymapolyspora)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.(Naegleriagruberi)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.(Naegleriagruberi)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.(Bos taurus)
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.(Neisseriagonorrhoeae)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.(Streptococcusagalactiae)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.(Streptococcusagalactiae)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.(Acroporamillepora)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.(Acroporamillepora)